Related Experiment Video
Updated: Nov 12, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor
Yong-Li Dong1,2, Gangadhara P Vadla3, Jin-Yu Jim Lu1,4
1Howard Hughes Medical Institute, Department of Genetics, Yale University School of Medicine, Boyer Center for Molecular Medicine, New Haven, CT, USA.
Abstract:
Oncogenic RAS mutations are associated with tumor resistance to radiation therapy. Cell-cell interactions in the tumor microenvironment (TME) profoundly influence therapy outcomes. However, the nature of these interactions and their role in Ras tumor radioresistance remain unclear. Here we use Drosophila oncogenic Ras tissues and human Ras cancer cell radiation models to address these questions. We discover that cellular response to genotoxic stress cooperates with oncogenic Ras to activate JAK/STAT non-cell autonomously in the TME. Specifically, p53 is heterogeneously activated in Ras tumor tissues in response to irradiation. This mosaicism allows high p53-expressing Ras clones to stimulate JAK/STAT cytokines, which activate JAK/STAT in the nearby low p53-expressing surviving Ras clones, leading to robust tumor re-establishment. Blocking any part of this cell-cell communication loop re-sensitizes Ras tumor cells to irradiation. These findings suggest that coupling STAT inhibitors to radiotherapy might improve clinical outcomes for Ras cancer patients.
Insights
Oncogenic Ras mutations cause radiation resistance. A novel cell-cell communication pathway involving JAK/STAT signaling in the tumor microenvironment (TME) promotes tumor regrowth after radiation, suggesting new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Oncogenic RAS mutations are linked to tumor resistance to radiation therapy.
- The tumor microenvironment (TME) significantly impacts therapy outcomes, but its role in Ras-driven radioresistance is not fully understood.
Purpose of the Study:
- To investigate the mechanisms of cell-cell interactions in the TME that contribute to oncogenic Ras tumor radioresistance.
- To identify potential therapeutic targets for overcoming Ras-driven radioresistance.
Main Methods:
- Utilized Drosophila oncogenic Ras tissues and human Ras cancer cell radiation models.
- Investigated the role of p53 activation and JAK/STAT signaling in response to genotoxic stress.
- Examined the impact of blocking cell-cell communication pathways on tumor radioresistance.
Main Results:
- Discovered that genotoxic stress and oncogenic Ras cooperate to activate non-cell autonomous JAK/STAT signaling in the TME.
- Observed heterogeneous p53 activation in irradiated Ras tumor tissues, leading to cytokine stimulation.
- Demonstrated that blocking this JAK/STAT communication loop re-sensitizes Ras tumors to irradiation.
Conclusions:
- A novel cell-cell communication loop involving p53 and JAK/STAT signaling drives Ras tumor radioresistance.
- Targeting this pathway, potentially with STAT inhibitors combined with radiotherapy, could improve treatment outcomes for Ras-driven cancers.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage can Stall the Cell Cycle

